Should we target all visible areas at mpMRI suspicious for clinically significant prostate cancer in addition to the index lesion? Results from a two-institution series

Should we target all visible areas at mpMRI suspicious for clinically significant prostate cancer in addition to the index lesion? Results from a two-institution series

Show other versions (1)
Bibliographic Details
Main Authors: F. Scalvi, A. Stabile, R.J. Karnes, G. Motterle, N. Fossati, G. Gandaglia, F. Barletta, S. Scuderi, V. Cucchiara, L. Nocera, E. Zaffuto, D. Cignoli, G. Rosiello, D. Robesti, D. Cannoletta, E. Zito, M. Menean, E. Mazzone, P. Dell’Oglio, A. Salonia, P.I. Karakiewicz, F. Montorsi, F. De Cobelli, A. Briganti
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320353830

Similar Items

Similar Items